TROKENDI XR
Live / Registered — Registered and renewed (as of 17 Dec 2024)
What this means for you
Registered since 18 Mar 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Mar 2024).
Record
- Serial number
- 85644722
- Registration number
- 4498773
- Mark type
- Stylized text
- Filed
- 06 Jun 2012
- Published for opposition
- 11 Dec 2012
- Registered
- 18 Mar 2014
- Next maintenance due
- 18 Mar 2024
- Attorney of record
- Mark D. Simpson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
Owner
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
Prior registrations
Prosecution history
- 17 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 17 Dec 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 17 Dec 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 18 Jun 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 18 Jun 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Mar 2024 — TEAS SECTION 8 & 9 RECEIVED
- 18 Mar 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 May 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 May 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Nov 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 11 Nov 2020 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 09 Nov 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 09 May 2020 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 09 May 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL